Cargando…
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
Over the past decades, accumulating evidence has demonstrated a pivotal role of cholecystokinin type 2 receptor (CCK2R) in pain modulation. The established role of CCK2R activation in directly facilitating nociception has led to the development of several CCK2R antagonists, which have been shown to...
Autores principales: | Bernard, Amandine, Danigo, Aurore, Bourthoumieu, Sylvie, Mroué, Mohamad, Desmoulière, Alexis, Sturtz, Franck, Rovini, Amandine, Demiot, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618735/ https://www.ncbi.nlm.nih.gov/pubmed/34832967 http://dx.doi.org/10.3390/ph14111185 |
Ejemplares similares
-
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice
por: Bernard, Amandine, et al.
Publicado: (2022) -
The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?
por: Danigo, Aurore, et al.
Publicado: (2021) -
Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
por: Bouchenaki, Hichem, et al.
Publicado: (2022) -
Neuroprotective Effect of Erythropoietin against Pressure Ulcer in a Mouse Model of Small Fiber Neuropathy
por: Danigo, Aurore, et al.
Publicado: (2014) -
Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice
por: Bouchenaki, Hichem, et al.
Publicado: (2021)